Thymus tumor associated with primary immunodeficiency or Good syndrome

Authors

Keywords:

thymus, thymoma, thymectomy, Good syndrome, hipogammaglobulinemia.

Abstract

The case report of a 54 years patient is described, who was admitted to Hermanos Ameijeiras Clinical-Surgical Teaching Hospital in Havana city due to fever, hypotension and diarrhea, to which complicated respiratory difficulty was added during his hospitalization and he required mechanical ventilator support in the Intensive Care Unit. As a radiographic finding, a shade in the left lung was observed that turned out to be a thymoma; while the blood test revealed hipogammaglobulinemia. It was decided to carry out conventional thymectomy by means of midline sternotomy, after which the patient had a favorable clinical course and was discharged from the hospital 10 days later.

Downloads

Download data is not yet available.

References

1. Herrera Sánchez DA, León Pedroza JI, Vargas Camaño ME, Castrejón Vázquez MI. Síndrome de Good. Reporte de un caso. Rev Alergia México. 2017 [citado 06/06/2023];64(2):235–40. Disponible en: https://revistaalergia.mx/ojs/index.php/ram/article/view/194

2. Kabir A, Alizadehfar R, Tsoukas CM. Good’s syndrome. Front Immunol. 2021 [citado 06/06/2023];12. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35095915/

3. Cos Esquius ML, López Montesinos I, Gimeno Martinez R, Eguía Núñez J, Caballero Rabasco MA, Sánchez González B, et al. Severe COVID-19 pneumonia in Good syndrome with a favorable outcome. Clin Immunol. 2022 [citado 06/06/2023];235(108789). Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1521661621001261?via%3Dihub

4. Li Y, Yao Z, Jiang M, Nie Y, Chen R, Liang N, et al. Clinical manifestations and long-term prognosis of Good syndrome: Results from a single-center cohort study from China. Mod Rheumatol. 2021 [citado 06/06/2023];31(5):1019-24. Disponible en: https://academic.oup.com/mr/article-abstract/31/5/1019/6365910?redirectedFrom=fulltext&login=false

5. Martín C, Enrico D, Mas L, Patane AK, Arrieta O, Soria T, et al. Characteristics and outcomes of thymomas in Latin America: Results from over 10 years of experience (CLICaP-LATimus). Thorac Cancer. 2021 [citado 06/06/2023];12(9):1328-35. Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/1759-7714.13901

6. Chen S, Liu J, Lin Y, Gao Y. Good’s syndrome with a relapsed bloodstream infection induced by alcaligenes sp. after thymectomy a case report. Exp Ther Med. 2021 [citado 06/06/2023];21(4):399. Disponible en: https://www.spandidos-publications.com/10.3892/etm.2021.9830

7. Chin Tong K, Yiu Cheong Y Good’s syndrome presenting with CMV pneumonitis and oesophageal candidiasis: A case report. Respirol Case Rep. 2021 [citado 06/06/2023];10(1):e0888. Disponible en: https://onlinelibrary.wiley.com/doi/10.1002/rcr2.888

8. Luzzi L, Corzani R, Ghisalberti M, Meniconi F, De Leonibus L, Molinaro F, et al. Robotic surgery vs. open surgery for thymectomy, a retrospective case-match study. J Robot Surg. 2021 [citado 06/06/2023];15(3):375–9. Disponible en: https://link.springer.com/article/10.1007/s11701-020-01109-z

9. Pasquini G, Menichelli C, Pastore G, Casamassima F, Fabrini MG, Cappelli S, et al. Stereotactic body radiation therapy for the treatment of pleural metastases in patients with thymoma: a retrospective review of 22 patients. J Thorac Dis. 2021 [citado 06/06/2023];13(11):6373–80. Disponible en: https://jtd.amegroups.org/article/view/58114/html

10. Duarte M, Faria L, Patronillo C, Costa Fernandes S da, Seara V. A case of severe COVID-19 in a patient with Good’s syndrome. Eur J Case Rep Intern Med. 2021 [citado 06/06/2023];8(10). Disponible en: https://www.ejcrim.com/index.php/EJCRIM/article/view/2976

Downloads

Published

2023-10-16

How to Cite

1.
Vázquez Arizmendi J, Fuentes Valdés E, Pérez García K. Thymus tumor associated with primary immunodeficiency or Good syndrome. MEDISAN [Internet]. 2023 Oct. 16 [cited 2025 Jun. 2];27(5):e4554. Available from: https://medisan.sld.cu/index.php/san/article/view/4554

Issue

Vol. 27 No. 5 (2023): SEPTIEMBRE-OCTUBRE

Section

Case Reports

License

All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.